Medical imaging and research company Resonance Health (ASX: RHT) continues to advance a new artificial intelligence solution for automated alerts for patients with a suspected pulmonary embolism (PE), blood clots that block arteries in the lungs. The research and development has now led to the Pre-Submission filing of ALERT-PE to the United States Food and
Read More
Investors that missed out on the IPO for medtech company 4D Medical (ASX: 4DX) have had no qualms buying the stock on market with shares in 4DX opening at $1.47 when trading commenced this morning, more than double the IPO Offer Price of $0.73. The significant jump follows a similar trend among Australian investors that
Read More
Australian medtech company Mach7 Technologies (ASX: M7T) has continued to strengthen its position in the Hong Kong market, securing new licencing orders of $4.8m, adding to their existing 5-year contract to supply medical imaging solutions to the entire territory of Hong Kong. The new AUD $4.8m is expected to be logged as cash collected within
Read More